Thanks.
That was a great interview.
Nearly 2 weeks to go to Dec 10. Very exciting. Fingers crossed the results are as expected.
An increase in investment next year in 6302.
Regarding FDA nothing has changed in my view. They will need the 12 month results in March to take to FDA. The 9th month results on Dec 10 will provide a very good indication. All the competing drugs that have had big $ spent and traded are dropping away with side effects. Looks like SNT will have the field to itself with its unique mode of action and excellent safety profile and tolerability. A great position to be in when dealing with big pharma.
Add to My Watchlist
What is My Watchlist?
